BLUE HAT INTERACTIVE ENTERTA (BHAT)

KYG1329V2058 - Common Stock

0.15  0 (0%)

Fundamental Rating

1

BHAT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. BHAT may be in some trouble as it scores bad on both profitability and health. BHAT has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

BHAT had negative earnings in the past year.
In multiple years BHAT reported negative net income over the last 5 years.
In multiple years BHAT reported negative operating cash flow during the last 5 years.

1.2 Ratios

BHAT's Return On Assets of -26.68% is on the low side compared to the rest of the industry. BHAT is outperformed by 83.10% of its industry peers.
Looking at the Return On Equity, with a value of -78.83%, BHAT is doing worse than 70.42% of the companies in the same industry.
Industry RankSector Rank
ROA -26.68%
ROE -78.83%
ROIC N/A
ROA(3y)-57.68%
ROA(5y)-27.06%
ROE(3y)-146.55%
ROE(5y)-78.27%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BHAT has a better Gross Margin (54.20%) than 61.97% of its industry peers.
BHAT's Gross Margin has declined in the last couple of years.
BHAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.46%
GM growth 5Y-2.81%

2

2. Health

2.1 Basic Checks

BHAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BHAT has been increased compared to 5 years ago.
BHAT has a worse debt/assets ratio than last year.

2.2 Solvency

BHAT has an Altman-Z score of -1.64. This is a bad value and indicates that BHAT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.64, BHAT is not doing good in the industry: 80.28% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.14 indicates that BHAT is not too dependend on debt financing.
BHAT's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. BHAT outperforms 66.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -1.64
ROIC/WACCN/A
WACC6.35%

2.3 Liquidity

BHAT has a Current Ratio of 1.26. This is a normal value and indicates that BHAT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BHAT (1.26) is comparable to the rest of the industry.
BHAT has a Quick Ratio of 1.26. This is a normal value and indicates that BHAT is financially healthy and should not expect problems in meeting its short term obligations.
BHAT has a Quick ratio of 1.26. This is comparable to the rest of the industry: BHAT outperforms 59.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.12% over the past year.
Looking at the last year, BHAT shows a very negative growth in Revenue. The Revenue has decreased by -51.32% in the last year.
BHAT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.19% yearly.
EPS 1Y (TTM)89.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.35%
Revenue 1Y (TTM)-51.32%
Revenue growth 3Y-32.34%
Revenue growth 5Y-12.19%
Sales Q2Q%2639.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHAT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BHAT!.
Industry RankSector Rank
Dividend Yield N/A

BLUE HAT INTERACTIVE ENTERTA

NASDAQ:BHAT (11/29/2024, 11:30:02 AM)

0.15

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.76M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.68%
ROE -78.83%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 54.2%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)89.12%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-51.32%
Revenue growth 3Y-32.34%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y